Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Abbas

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Molecular Cancer Research : MCR|February 25, 2017
The E3 Ligase CHIP Mediates p21 Degradation to Maintain RadioresistanceKuntal Biswas, Sukumar Sarkar, Kangping Du, et al.
Molecular and Cellular Biology|June 17, 2004
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53Li Hui, Tarek Abbas, Rafal M Pielak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2020
Intrinsically disordered protein RBM14 plays a role in generation of RNA:DNA hybrids at double-strand break sitesYumi Jang, Zeinab Elsayed, Rebeka Eki, et al.
Nucleic Acids Research|October 17, 2020
A robust CRISPR-Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repairRebeka Eki, Jane She, Mahmut Parlak, et al.
Nucleic Acids Research|October 31, 2021
MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damageTeressa Paulsen, Pumoli Malapati, Yoshiyuki Shibata, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and TumorsVanessa Vanderdys, Amir Allak, Fadila Guessous, et al.
Ebiomedicine|June 23, 2016
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanomaMouadh Benamar, Fadila Guessous, Kangping Du, et al.
The Journal of Biological Chemistry|August 17, 2002
Differential activation of p53 by the various adducts of mitomycin CTarek Abbas, Magali Olivier, Jaqueline Lopez, et al.
Nucleic Acids Research|September 4, 2023
ZEB1 promotes non-homologous end joining double-strand break repairThomas L Genetta, Joshua C Hurwitz, Evan A Clark, et al.
Nephron. Clinical Practice|February 11, 2005
Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysisHussein Sheashaa, Waleed Abdel-Razek, Amr El-Husseini, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Molecular Cancer Research : MCR|February 25, 2017
The E3 Ligase CHIP Mediates p21 Degradation to Maintain RadioresistanceKuntal Biswas, Sukumar Sarkar, Kangping Du, et al.
Molecular and Cellular Biology|June 17, 2004
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53Li Hui, Tarek Abbas, Rafal M Pielak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2020
Intrinsically disordered protein RBM14 plays a role in generation of RNA:DNA hybrids at double-strand break sitesYumi Jang, Zeinab Elsayed, Rebeka Eki, et al.
Nucleic Acids Research|October 17, 2020
A robust CRISPR-Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repairRebeka Eki, Jane She, Mahmut Parlak, et al.
Nucleic Acids Research|October 31, 2021
MicroDNA levels are dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA damageTeressa Paulsen, Pumoli Malapati, Yoshiyuki Shibata, et al.
Molecular Cancer Therapeutics|August 26, 2017
The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and TumorsVanessa Vanderdys, Amir Allak, Fadila Guessous, et al.
Ebiomedicine|June 23, 2016
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanomaMouadh Benamar, Fadila Guessous, Kangping Du, et al.
The Journal of Biological Chemistry|August 17, 2002
Differential activation of p53 by the various adducts of mitomycin CTarek Abbas, Magali Olivier, Jaqueline Lopez, et al.
Nucleic Acids Research|September 4, 2023
ZEB1 promotes non-homologous end joining double-strand break repairThomas L Genetta, Joshua C Hurwitz, Evan A Clark, et al.
Nephron. Clinical Practice|February 11, 2005
Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysisHussein Sheashaa, Waleed Abdel-Razek, Amr El-Husseini, et al.
Pageof 5